tACS for Stroke Recovery
Trial Summary
What is the purpose of this trial?
The overall goal is to investigate the effectiveness of a novel intervention - transcranial alternating current stimulation (tACS) for motor recovery in stroke survivors.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently adjusting medications that affect muscle tone, like baclofen.
What data supports the effectiveness of the treatment tACS for stroke recovery?
Research on a similar treatment, transcranial direct current stimulation (tDCS), shows it can help improve motor function in stroke patients, especially those with chronic or mild-to-moderate impairments. This suggests that tACS, which is another form of brain stimulation, might also be beneficial for stroke recovery.12345
How does tACS differ from other stroke recovery treatments?
Transcranial alternating current stimulation (tACS) is unique because it uses non-invasive electrical currents to modulate brain activity, potentially enhancing recovery by improving neurological function and brain blood flow in stroke patients. Unlike traditional therapies, tACS specifically targets brain oscillations at different frequencies to influence motor control and brain network integration, offering a novel approach to stroke rehabilitation.678910
Research Team
Sheng Li, MD, PhD
Principal Investigator
The University of Texas Health Science Center, Houston
Eligibility Criteria
This trial is for stroke survivors aged 18-75 who are at least 6 months post-stroke, can move their finger flexors slightly, and give consent. It's not for those with visual/hearing/cognitive impairments, recent botulinum/phenol injections, pacemakers/metal implants/oxygen therapy or women who are pregnant.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive tACS intervention for motor recovery, with sessions involving 10Hz or 20Hz stimulation for 20 or 40 minutes
Follow-up
Participants are monitored for changes in motor function and EEG activity after the tACS intervention
Treatment Details
Interventions
- tACS 10Hz
- tACS 20Hz
- tACS Sham
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor